MRI-based radiomics to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A multicenter study

医学 鼻咽癌 内科学 肿瘤科 诱导化疗 放化疗 阶段(地层学) 化疗 放射治疗 古生物学 生物
作者
Hesong Shen,Jinxue Yin,Running Niu,Yanbang Lian,Yuanying Huang,Chunrong Tu,Daihong Liu,Xiaoxia Wang,Xiaosong Lan,Xiaoqian Yuan,Jiuquan Zhang
出处
期刊:Radiotherapy and Oncology [Elsevier BV]
卷期号:171: 107-113 被引量:11
标识
DOI:10.1016/j.radonc.2022.04.017
摘要

Background and purpose It remains uncertain whether induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT) or CCRT plus adjuvant chemotherapy (AC) is more effective in patients with locoregionally advanced nasopharyngeal carcinoma (LA-NPC). This study aimed to develop and validate a joint radiomic and clinical signature (RCS) for the prognostic stratification of LA-NPCs and to identify patients who might benefit more from IC + CCRT or CCRT + AC. Materials and methods Overall, 893 LA-NPC patients who received IC + CCRT or CCRT + AC were enrolled from four hospitals. RCS based on pretreatment magnetic resonance images and clinical data was constructed for predicting 5-year progression-free survival (PFS). The predictive ability of the RCS and TNM staging system for 5-year PFS, locoregional relapse-free survival (LRRFS), distant metastasis-free survival (DMFS) and overall survival (OS) were compared by Harrell’s concordance indices (C-indices). Patients were divided into high- and low-risk subgroups based on RCS scores. The survival benefit of IC + CCRT vs. CCRT + AC in different subgroups was compared by Kaplan–Meier survival curves. Results The RCS combining the radiomic signature, TNM stage and EBV DNA demonstrated significantly higher C-indices than TNM stage for predicting 5-year PFS, LRRFS, DMFS and OS in the training and validation cohorts. In the high-risk group (RCS score ≥ 0.25), CCRT + AC achieved significantly better PFS, LRRFS, DMFS and OS than IC + CCRT. In the low-risk group (RCS score < 0.25), IC + CCRT yielded significantly better outcomes than CCRT + AC. Conclusion The RCS provides a noninvasive way to predict the outcomes of LA-NPC and helps identify patients who may benefit more from IC + CCRT vs. CCRT + AC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
wht发布了新的文献求助10
2秒前
赘婿的应助被伶俐老头采纳,获得10
2秒前
隐形白亦完成签到,获得积分10
3秒前
Liu_letters的应助被哔哩哔哩采纳,获得10
3秒前
黄123huang_发布了新的文献求助10
4秒前
虚心代天完成签到,获得积分10
4秒前
CipherSage的应助被小橘子采纳,获得10
4秒前
南桉发布了新的文献求助10
6秒前
6秒前
8秒前
9秒前
超级无敌泰迪战士完成签到,获得积分10
10秒前
10秒前
BZW完成签到,获得积分10
11秒前
顺顺完成签到,获得积分10
11秒前
11秒前
水母大王完成签到,获得积分10
11秒前
12秒前
汉堡包的应助被dabai采纳,获得10
13秒前
共享精神的应助被thq采纳,获得10
13秒前
YANG发布了新的文献求助10
14秒前
15秒前
15秒前
小橘子发布了新的文献求助10
16秒前
洛枝发布了新的文献求助10
17秒前
飘逸的星星完成签到,获得积分10
17秒前
Hello的应助被无辜的笑蓝采纳,获得10
18秒前
19秒前
19秒前
吃葡萄不吐葡萄皮的应助被FG采纳,获得10
20秒前
20秒前
zcyuqing发布了新的文献求助10
21秒前
lili完成签到 ,获得积分10
22秒前
桐桐的应助被YANG采纳,获得10
24秒前
24秒前
卡皮巴拉完成签到,获得积分10
24秒前
25秒前
thq发布了新的文献求助10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153573
求助须知:如何正确求助?哪些是违规求助? 9550279
关于积分的说明 21697424
捐赠科研通 7742161
什么是DOI,文献DOI怎么找? 3425546
关于科研通互助平台的介绍 2550636
邀请新用户注册赠送积分活动 2469181